Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-12 ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec Option exercise · Restricted Stock Unit −2,697 0
2020-02-12 ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec Option exercise · Restricted Stock Unit −1,535 8,485
2020-02-12 ALEXANDER SUSAN H EVP Chief Legal Off & Corp Sec Other disposition · Restricted Stock Unit −1,803 6,682
2020-02-12 Vounatsos Michel Chief Executive Officer Option exercise +6,234 28,063.32
2020-02-12 Vounatsos Michel Chief Executive Officer Shares withheld for taxes −2,340 $331.76 $776K 25,723.32
2020-02-12 Vounatsos Michel Chief Executive Officer Option exercise +5,760 31,483.32
2020-02-12 Vounatsos Michel Chief Executive Officer Shares withheld for taxes −2,555 $331.76 $848K 28,928.32
2020-02-12 Vounatsos Michel Chief Executive Officer Option exercise · Restricted Stock Unit −6,234 17,982
2020-02-12 Vounatsos Michel Chief Executive Officer Other disposition · Restricted Stock Unit −5,870 12,112
2020-02-12 Vounatsos Michel Chief Executive Officer Option exercise · Restricted Stock Unit −5,760 31,810
2020-02-12 Vounatsos Michel Chief Executive Officer Other disposition · Restricted Stock Unit −6,762 25,048
2020-02-12 Vounatsos Michel Chief Executive Officer Grant or award · Restricted Stock Unit +37,680 37,680
2020-02-12 Sandrock Alfred EVP, Research & Development Option exercise +2,211 12,702.25
2020-02-12 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −660 $331.76 $219K 12,042.25
2020-02-12 Sandrock Alfred EVP, Research & Development Option exercise +1,422 13,464.25
2020-02-12 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −538 $331.76 $178K 12,926.25
2020-02-12 Sandrock Alfred EVP, Research & Development Option exercise +1,583 14,509.25
2020-02-12 Sandrock Alfred EVP, Research & Development Shares withheld for taxes −703 $331.76 $233K 13,806.25
2020-02-12 Sandrock Alfred EVP, Research & Development Option exercise · Restricted Stock Unit −2,211 0
2020-02-12 Sandrock Alfred EVP, Research & Development Option exercise · Restricted Stock Unit −1,422 4,106

Page 46 of 61 · 1,204 trades